Trials / Unknown
UnknownNCT04507711
Palonosetron and Blood Coagulation
The Effect of a Palonosetron on Blood Coagulation: In Vitro, Volunteer Study Using Thromboelastography
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Palonosetron may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of palonosetron. The investigators therefore will perform the present study to measure the effect of palonosetron levels using thromboelastography.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0 ul of palonosetron | Venous blood is taken from 11 healthy volunteers and divided into four specimen bottles, which were added with different doses (0 ul) using palonosetron |
| DRUG | 1 ul of palonosetron | Venous blood is taken from 11 healthy volunteers and divided into four specimen bottles, which were added with different doses (1 ul) using palonosetron |
| DRUG | 10 ul of palonosetron | Venous blood is taken from 11 healthy volunteers and divided into four specimen bottles, which were added with different doses (10 ul) using palonosetron |
| DRUG | 100 ul of palonosetron | Venous blood is taken from 11 healthy volunteers and divided into four specimen bottles, which were added with different doses (100 ul) using palonosetron |
Timeline
- Start date
- 2020-09-16
- Primary completion
- 2023-11-15
- Completion
- 2023-12-15
- First posted
- 2020-08-11
- Last updated
- 2023-03-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04507711. Inclusion in this directory is not an endorsement.